Alexander J. Hodakowski

Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US

Shruti Gupta, Salim S. Hayek, Wei Wang et al. · JAMA Internal Medicine · 2020 · 1K citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +12

Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Shruti Gupta, Wei Wang, Salim S. Hayek et al. · JAMA Internal Medicine · 2020 · 555 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +16

Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19

Hanny Al‐Samkari, Shruti Gupta, Wei Wang et al. · Annals of Internal Medicine · 2021 · 140 citations · Full text

Medicine, Hematology, Infectious Diseases +17

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14